A systems level analysis of epileptogenesis-associated proteome alterations
Michael Keck1, Anna Fournier2, Fabio Gualtieri1
1Institute of Pharmacology, Toxicology and Pharmacy, Ludwig-Maximilians-University (LMU), 80539 Munich, Germany.
Neurobiology of Disease
|June 4, 2017
Summary
This study reveals new molecular pathways in epilepsy development using systems-level proteomic analysis in a rat model. Findings offer potential biomarkers and therapeutic targets for epilepsy prevention and treatment.
Area of Science:
- Neuroscience
- Molecular Biology
- Systems Biology
Background:
- Epileptogenesis and epilepsy mechanisms remain incompletely understood.
- Identifying molecular targets is crucial for developing novel biomarkers and therapies.
Purpose of the Study:
- To perform a comprehensive systems-level analysis of proteomic data from a chronic rat epileptogenesis model.
- To identify molecular pathways and potential biomarkers associated with epilepsy development.
Main Methods:
- Weighted Gene Co-expression Network analysis (WGCNA) of proteomic data.
- Analysis of hippocampus and parahippocampal cortex tissues across different phases of epileptogenesis.
- Principal Component Analysis (PCA) for biomarker identification.
Main Results:
- WGCNA identified distinct protein modules linked to epileptogenesis in specific brain regions.
- New molecular processes potentially involved in epilepsy development were uncovered.
- Temporal patterns in molecular alterations were observed, relevant for preventive strategies.
- PCA suggested candidate biomarkers for predicting epileptogenesis and confirming epilepsy.
Conclusions:
- Proteomic network analysis provides insights into molecular mechanisms of epileptogenesis.
- Identified molecular patterns and biomarkers can inform novel diagnostic and therapeutic strategies.
- Further research is needed to differentiate between epileptogenesis-correlated alterations and consequences of seizures.
Related Concept Videos
Proteomics
10.0K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
10.0K
Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K


